Polski Lek

What Polski Lek does

Polski Lek Sp. z o.o. is a Polish developer, manufacturer, and distributor of dietary supplements and over-the-counter (OTC) pharmaceutical products, headquartered in Wadowice, Poland. Founded in 2000 and operating with 501–1,000 employees, the company manages a portfolio of over 20 brands and 100+ products across therapeutic areas including pediatrics, gynecology/prenatal care, laryngology, vitamin and mineral supplementation, electrolytes, allergy support, and senior health. Its proprietary technology base includes film-coated, sugar-coated, and uncoated tablets; single-layer and two-layer effervescent tablets (with the proprietary "Plusssz Fusion System" launched in 2006 representing a first-to-market dual-layer effervescent delivery technology); granules and powders in sachets; and lozenges. Manufacturing adheres to GMP guidelines and IFS Food version 6 at higher level, and the company holds HACCP certification.

The company operates three primary revenue streams: (1) own-brand consumer product sales through pharmacy and retail distribution (brands such as Plusssz, Prenalen, Omegamed, Actiferol, Actifolin, Entitis, Pedicetamol, Bobolen, Verbascon, and SOLbaby); (2) contract manufacturing services for third-party clients covering technology and recipe development, finished product documentation, trials, and packaging across tablets, effervescent tablets, granules, and powders; and (3) pharmaceutical wholesale distribution via its wholly-owned subsidiary Polski Lek – Dystrybucja Sp. z o.o. (established 2010), which also handles direct deliveries to pharmacies. Distribution is augmented by an Export Department serving international markets, with the products developed based on scientific research and targeted at sensitive consumer groups including pregnant women, infants, and children, alongside adult and senior demographics.

Since 2005, Polski Lek has been a wholly-owned subsidiary of Maspex Group, one of the largest food and beverage conglomerates in Central and Eastern Europe. A January 30, 2026 announced merger plan between Polski Lek – Dystrybucja Sp. z o.o. (acquiring company) and Polski Lek Sp. z o.o. (acquired company) indicates an ongoing consolidation of the corporate structure. Brand recognition is supported by multiple industry accolades including Effie Awards (2000, 2008, 2023), Superbrands 2024, Konsumencki Lider Jakości (Consumer Quality Leader) awards across multiple years and product categories, and Laur Klienta awards.

Name

Polski Lek

Legal name

Polski Lek Sp. z o.o.

Website

https://polskilek.pl/pl

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Polski Lek is a Polish manufacturer and distributor of dietary supplements and OTC pharmaceutical products, serving sensitive consumer groups (pregnant women, infants, children, adults, seniors) through 20+ proprietary brands, contract manufacturing services, and a wholesale subsidiary under Maspex Group.

Ownership category

akta.pro rank

Product category

Dietary Supplements

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Multivitamins & Daily Packs (CRADAGAC)

akta.pro secondary industries

Children’s Vitamins & Supplements (CRADAGAJ), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Healthy Aging & Cognitive Support Supplements (CRADAGAM), Vitamins & Minerals (Single Nutrients) (CRADAGAB), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

Keywords

• Dietary supplements
• Contract manufacturing
• Pharmaceutical wholesale
• Effervescent tablets
• Pediatric nutrition

Headquarters

HQ city

Wadowice

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Own Brand Product Sales: Sale of proprietary dietary supplement brands including Plusssz, Prenalen, Omegamed, Actiferol, Actifolin, Entitis, Pedicetamol, Bobolen, Verbascon, SOLbaby and others to consumers via pharmacies and retail.
2. Contract Manufacturing Services: Provides comprehensive contract manufacturing services for foodstuffs, particularly dietary supplements and enriched products. Services include technology and recipe development, finished product documentation, technological trials, and packaging services for tablets, effervescent tablets, granules and powders under client brands or their own branding.
3. Pharmaceutical Wholesale: Polski Lek Dystrybucja Sp. z o.o. operates as a pharmaceutical warehouse handling medicinal products, medical devices, and dietary supplements with distribution to pharmacies since 2010.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Polski Lek Sp. z o.o. develops, manufactures and distributes a portfolio of dietary supplements, OTC pharmaceutical products and pediatric formulations sold under more than 20 proprietary brands (Plusssz, Prenalen, Omegamed, Actiferol, Actifolin, Entitis, Pedicetamol, Bobolen, Verbascon, SOLbaby, Vital Senior, Tabletki Emskie z Wadowic and others). The company also offers contract manufacturing services for tablets, effervescent tablets, granules and powders, and operates a pharmaceutical wholesale subsidiary (Polski Lek Dystrybucja Sp. z o.o.) serving Polish pharmacies.

Differentiator

Problem solved

Functional benefit

Brands

• Plusssz: Primary brand offering effervescent supplements, electrolytes, multivitamins, and vitamin shots for various consumer segments.
• Actiferol
• Actifolin
• Entitis
• Omegamed
• Pedicetamol
• Bobolen
• Prenalen
• Verbascon
• SOLbaby
• Sundovit
• Vital Senior
• Dr Vitt
• Finsla
• Chiro
• Gastrimax
• Joint DUO
• Medistav
• Gynauxil
• Climeston
• Tabletki Emskie z Wadowic
• Miositogyn GT

Products and services

• Plusssz brand (effervescent supplements, electrolytes, multivitamins, vitamin shots) Primary Polski Lek brand offering effervescent supplements, electrolyte products, multivitamins, and vitamin shots for adults and seniors, sold through pharmacies and retail.
• Prenalen brand Prenatal and maternal health brand offering supplements for pregnancy, nausea relief, and immune support for expectant mothers.
• Omegamed brand Omega-3 and DHA supplement brand serving infants, children, and adults, with formulations specifically for pregnancy and early childhood development.
• Actiferol brand Iron supplement brand offering formulations for adults, children and infants to address iron deficiency.
• ActiFolin brand Folic acid supplement brand with specialized formulations for pregnant women and maternal nutrition.
• Entitis brand Probiotic supplement brand targeting throat and ENT health, with pediatric formulations for children.
• Pedicetamol brand Pediatric paracetamol analgesic brand formulated for children.
• Bobolen brand Brand offering dietary supplements for infants and children including vitamin D and marshmallow-based syrups.
• Verbascon brand Brand offering products for cold, flu, and sinus relief.
• SOLbaby brand Baby care brand offering aroma patches and other infant-focused products.
• Tabletki Emskie z Wadowic brand Traditional lozenge brand from the Wadowice region, with a 2025 EXTRA variant enhanced with vitamin A and zinc.
• Finsla brand Throat and laryngology product brand offering lozenges for voice and respiratory comfort.
• Joint DUO brand Joint and muscle health supplement brand including glucosamine-based Duo Stawy MaxiFlex Glukozamina products, with a 2025 Senior variant.
• Vital Senior product line Senior health supplement product line including omega-3, glucosamine, collagen, anti-cramp, liver, neuro, and sleep supplements targeting the senior demographic.
• Plusssz Up Shot series Liquid vitamin shot range launched in 2025 under the Plusssz Up brand covering collagen, caffeine energy, immune complex vitamin C, B-complex neuro support, and magnesium citrate formulations.
• Plusssz Gluco Control Dietary supplement launched in 2025 to support healthy blood sugar levels.
• Plusssz B-Complex Neuro Balance B-complex vitamin supplement launched in 2025 with added neuro support formulation.
• Plusssz Elektrolity Senior Dobry Dzień Electrolyte supplement formulated and branded for the senior segment under the 'Dobry Dzień' line, launched in 2025.
• Plusssz Elektrolity Senior Serce Electrolyte supplement formulated for seniors with added cardiovascular support formulation, launched in 2025.
• Contract manufacturing services B2B contract manufacturing of dietary supplements and enriched food products: tablets, effervescent tablets, granules and powders produced under client brands. Includes technology/recipe development, documentation, technological trials and packaging services, executed under GMP and IFS Food v6 standards.
• Pharmaceutical wholesale (Polski Lek Dystrybucja Sp. z o.o.) Wholesale distribution of medicinal products, medical devices, and dietary supplements to Polish pharmacies, operated through wholly-owned subsidiary Polski Lek Dystrybucja Sp. z o.o.

Quantifiable outcome

• Consumer Quality Leader 2024 - Plusssz Elektrolity in electrolytic preparations category
• +2 more outcomes

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Aflofarm Farmacja Polska: One of the largest Polish OTC and dietary supplement manufacturers, with a comparable multi-brand portfolio distributed through pharmacy channels and overlapping consumer segments (children, adults, seniors). Closest direct competitor on the Polish market.
• USP Zdrowie: Polish pharmaceutical company producing OTC drugs, dietary supplements, and medical devices distributed via pharmacies. Strong overlap in product format (tablets, effervescent) and channels with Polski Lek.
• Biofarm: Polish contract manufacturer and OTC drug producer offering tablets, effervescent tablets, and supplements; comparable combination of own-brand and contract manufacturing services.
• Hasco-Lek: Polish pharmaceutical manufacturer with OTC and supplement products distributed via pharmacies; comparable portfolio breadth and pharmacy-channel orientation.
• PPF Hasco (Hasco TM): Polish pharmaceutical company in the Hasco group producing OTC drugs and supplements; competes with Polski Lek in pharmacy retail and contract manufacturing.
• Galena: Polish pharmaceutical manufacturer focused on OTC and dietary supplements with pharmacy distribution; overlapping target customer segments and product formats.

Regional players

• Krka: Slovenian generic and OTC pharmaceutical producer with strong CEE presence; comparable in manufacturing scale and pharmacy distribution, though based in Slovenia rather than Poland.
• Gedeon Richter: Hungarian pharmaceutical group with OTC and women's health portfolio overlapping with Polski Lek's Prenalen/ActiFolin and Chiro ranges; significant CEE pharmacy presence.

Broad incumbents

• Bayer Consumer Health: Global OTC and supplement player (e.g., Berocca, Elevit, Supradyn) competing directly with Plusssz and prenatal/supplement brands across CEE; broader portfolio but overlapping categories.
• Perrigo Company: Large OTC and consumer self-care company selling store-brand and branded supplements in European pharmacies; meaningful competitor in the same shelf and channel as Polski Lek.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/people/Polski-Lek/61553885657243
• LinkedInlinkedin.com/company/polski-lek

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Polski Lek